Trials / Unknown
UnknownNCT05653596
VR-based Intervention for Cognitive Restoration
Virtual Reality-Based Cognitive Intervention for Women With Cognitive Complaints Following Breast Cancer Treatment
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Chungnam National University · Academic / Other
- Sex
- Female
- Age
- 19 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to test the efficacy of a nature-based cognitive intervention to restore cognitive function among women treated for breast cancer.
Detailed description
Cognitive dysfunction is a kind of cluster of commonly reported neurotoxic symptoms following cancer diagnosis and treatment, especially chemotherapy. Our previous studies found that breast cancer patients and survivors had greater difficulties in performing attention, working memory, and executive function tasks and had persistent neural inefficiency of an executive network of the brain than disease and treatment counterparts. The aim of this study is to test the efficacy of a nature-based cognitive intervention to restore cognitive function among women with cognitive complaints after breast cancer treatment. All participants will receive the initial screening to verify their cognitive status and then will be randomly assigned to the experimental or control group. The experimental group will receive a 4-week cognitive intervention by using a VR headset. Each VR content includes 10-12 video scenes with visual and auditory stimuli that were generated from nature.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Virtual reality-based cognitive intervention | This intervention consists of 12 different VR contents that were developed for this trial. Each content includes 10-12 scenes with visual and auditory stimuli generated from nature. Participants will view 3D nature videos using a VR headset for 20 minutes every other day, three times per week for one month. |
Timeline
- Start date
- 2019-12-10
- Primary completion
- 2025-02-28
- Completion
- 2025-07-31
- First posted
- 2022-12-16
- Last updated
- 2024-02-06
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05653596. Inclusion in this directory is not an endorsement.